scispace - formally typeset
S

Stephen V. Faraone

Researcher at State University of New York Upstate Medical University

Publications -  1470
Citations -  155368

Stephen V. Faraone is an academic researcher from State University of New York Upstate Medical University. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Bipolar disorder. The author has an hindex of 188, co-authored 1427 publications receiving 140298 citations. Previous affiliations of Stephen V. Faraone include University of Bergen & National Institute for Health Research.

Papers
More filters
Journal ArticleDOI

A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects.

TL;DR: The results do not support an association between deficits in growth outcomes and either ADHD or psychostimulant treatment for ADHD, and should assist clinicians and parents in formulating treatment plans for children with ADHD.
Journal ArticleDOI

A double-blind comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder.

TL;DR: Treatment with desipramine was well tolerated and was associated with robust clinically significant reductions in tic and ADHD symptoms in children and adolescents with chronic tic disorders and ADHD diagnoses.
Journal ArticleDOI

Are cognitive deficits in attention deficit/hyperactivity disorder related to the course of the disorder? A prospective controlled follow-up study of grown up boys with persistent and remitting course

TL;DR: Main group effects indicated that persistent and remittent ADHD groups both had significantly lower scores on all cognitive outcomes compared with controls, and these did not differ between the ADHD subgroups Psychometrically defined cognitive deficits are relatively stable into young adult years and appear to be independent of the course of ADHD.
Journal Article

Does Stimulant Treatment Lead to Substance Use Disorders

TL;DR: Exposure to stimulant therapy for ADHD does not increase the risk for developing substance use disorders but is, in fact, protective against it, and Stimulant treatment of ADHD appears to reduce the risk of substance use disorder in ADHD youth to levels well within the normal population risk.
Journal ArticleDOI

Attention-deficit disorder and conduct disorder in girls: evidence for a familial subtype

TL;DR: It is suggested that ADHD with and without antisocial disorders may be etiologically distinct disorders and evidence for the nosologic validity of ICD-10 hyperkinetic conduct disorder is provided.